References
- I. A. Scott, S. N. Hilmer, E. Reeve, K. Potter, D. Le Couteur, D. Rigby, D. Gnjidic, C. B. Del Mar, E. E. Roughead, A. Page, J. Jansen and J. H. Martin, Reducing inappropriate polypharmacy: the process of deprescribing, JAMA Intern. Med. 175(5) (2015) 827–834; https://doi.org/10.1001/jamainternmed.2015.0324
- M. C. Woodward, Deprescribing: achieving better health outcomes for older people through reducing medications, J. Pharm. Pract. Res. 33 (2003) 323–328; https://doi.org/10.1002/jppr2003334323
- E. Reeve, D. Gnjidic, J. Long and S. Hilmer, A systematic review of the emerging definition of ‘depre-scribing’ with network analysis: implications for future research and clinical practice, Br. J. Clin. Pharmacol. 80(6) (2015) 1254–68; https://doi.org/10.1111/bcp.12732
- D. Gnjidic and E. Reeve, Deprescribing: What do we know, and where to next?, Br. J. Clin. Pharmacol. 87(3) (2021) 722–724; https://doi.org/10.1111/bcp.14525
- T. A. Boghossian, F. J. Rashid, W. Thompson, V. Welch, P. Moayyedi, C. Rojas-Fernandez, K. Pottie and B. Farrell, Deprescribing versus continuation of chronic proton pump inhibitor use in adults, Cochrane Database Syst. Rev. 3(3) (2017) CD011969; https://doi.org/10.1002/14651858.CD011969.pub2
- P. Haastrup, M. S. Paulsen, L. M. Begtrup, J. M. Hansen and D. E. Jarbøl, Strategies for discontinuation of proton pump inhibitors: a systematic review, Fam. Pract. 31(6) (2014) 625–630; https://doi.org/10.1093/fampra/cmu050
- T. D. Wilsdon, I. Hendrix, T. R. Thynne and A. A. Mangoni, Effectiveness of interventions to depre-scribe inappropriate proton pump inhibitors in older adults, Drugs Aging 34(4) (2017) 265–287; https://doi.org/10.1007/s40266-017-0442-1
- M. Gates, A. Gates, D. Pieper, R. M. Fernandes, A. C. Tricco, D. Moher, S. E. Brennan, T. Li, M. Pol-lock, C. Lunny, D. Sepúlveda, J. E. McKenzie, S. D. Scott, K. A. Robinson, K. Matthias, K. I. Bougioukas, P. Fusar-Poli, P. Whiting, S. J. Moss and L. Hartling, Reporting guideline for overviews of reviews of healthcare interventions: Development of the PRIOR statement, BMJ 378 (2022) Article ID e070849 (13 pages); https://doi.org/10.1136/bmj-2022-070849
- M. J. Page, J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, J. M. Tetzlaff, E. A. Akl, S. E. Brennan, R. Chou, J. Glanville, J. M. Grimshaw, A. Hróbjartsson, M. M. Lalu, T. Li, E. W. Loder, E. Mayo-Wilson, S. McDonald, L. A McGuinness, L. A Stewart, J. Thomas, A. C. Tricco, V. A. Welch, P. Whiting and D. Moher, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ 372 (2021) Article ID 71 (9 pages); https://doi.org/10.1136/bmj.n71
- A. Tong, K. Flemming, E. McInnes, S. Oliver and J. Craig, Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ, BMC Med. Res. Methodol. 12(181) (2012); https://doi.org/10.1186/1471-2288-12-181
- S. Jongstra, J. K. Harrison, T. J. Quinn and E. Richard, Antihypertensive withdrawal for the prevention of cognitive decline, Cochrane Database Syst. Rev. 11(11) (2016) Article ID CD011971 (49 pages); https://doi.org/10.1002/14651858.CD011971.pub2
- C. Parsons, W. Y. Lim, C. Loy, B. McGuinness, P. Passmore, S. A. Ward and C. Hughes, Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia, Cochrane Database Syst. Rev. 2(2) (2021) Article ID CD009081 (77 pages); https://doi.org/10.1002/14651858.CD009081.pub2
- E. Reeve, M. Ong, A. Wu, J. Jansen, M. Petrovic and D. Gnjidic, A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people, Eur. J. Clin. Pharmacol. 73(8) (2017) 927–935; https://doi.org/10.1007/s00228-017-2257-8
- A. M. S. Sørensen, S. Tarp, P. Johannsen, A. Lolk, E. Bandak, H. Pedersen, N. Saxtrup, H. Kallehauge, E. J. Solem and M. B. Christensen, Analgesics use and withdrawal in people with dementia – a register-based Danish study and a systematic review, Dan. Med. J. 66(12) (2019) Article ID A5578 (6 pages).
- E. Van Leeuwen, M. Petrovic, M. L. van Driel, A. I. De Sutter, R. Vander Stichele, T. Declercq and T. Christiaens, Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia, Cochrane Database Syst. Rev. 3(3) (2018) Article ID CD007726 (95 pages); https://doi.org/10.1002/14651858.CD007726.pub3
- A. M. Paquin, K. Zimmerman and J. L. Rudolph, Risk versus risk: a review of benzodiazepine reduction in older adults, Expert Opin. Drug Saf. 13(7) (2014) 919–934; https://doi.org/10.1517/14740338.2014.925444
- J. Davies and J. Read, A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based?, Addict. Behav. 97 (2019) 111–121; https://doi.org/10.1016/j.addbeh.2018.08.027
- K. Matsui, T. Tokumasu, Y. Takekita, K. Inada, T. Kanazawa, T. Kishimoto, S. Takasu, H. Tani, S. Tarutani, N. Hashimoto, H. Yamada, Y. Yamanouchi and H. Takeuchi, Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: a systematic review and meta-analysis, Schizophr. Res. 209 (2019) 50–57; https://doi.org/10.1016/j.schres.2019.05.030
- E. Maund, B. Stuart, M. Moore, C. Dowrick, A. W. A. Geraghty, S. Dawson and T. Kendrick, Managing antidepressant discontinuation: a systematic review, Ann. Fam. Med. 17(1) (2019) 52–60; https://doi.org/10.1370/afm.2336
- K. Monahan, J. Cuzens-Sutton, D. Siskind and S. Kisely, Quetiapine withdrawal: a systematic review, Aust. N. Z. J. Psychiatry 55(8) (2021) 772–783; https://doi.org/10.1177/0004867420965693
- K. Mugunthan, T. McGuire and P. Glasziou, Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis, Br. J. Gen. Pract. 61(590) (2011) e573–e578; https://doi.org/10.3399/bjgp11X593857
- J. M. Parr, D. J. Kavanagh, L. Cahill, G. Mitchell and R. McD Young, Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis, Addiction 104(1) (2009) 13–24; https://doi.org/10.1111/j.1360-0443.2008.02364.x
- P. R. S. Ribeiro and A. D. Schlindwein, Benzodiazepine deprescription strategies in chronic users: a systematic review, Fam. Pract. 38(5) (2021) 684–693; https://doi.org/10.1093/fampra/cmab017
- E. Van Leeuwen, M. L. van Driel, M. A. Horowitz, T. Kendrick, M. Donald, A. I. De Sutter, L. Robertson and T. Christiaens, Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults, Cochrane Database Syst. Rev. 4(4) (2021) Article ID CD013495 (211 pages); https://doi.org/10.1002/14651858.CD013495.pub2
- C. D. Black, W. Thompson, V. Welch, L. McCarthy, C. Rojas-Fernandez, H. Lochnan, S. Shamji, R. Upshur and B. Farrell, Lack of evidence to guide deprescribing of antihyperglycemics: a systematic review, Diabetes Ther. 8(1) (2017) 23–31; https://doi.org/10.1007/s13300-016-0220-9
- R. K. Boyapati, J. Torres, C. Palmela, C. E. Parker, O. M. Silverberg, S. D. Upadhyaya, T. M. Nguyen and J. F. Colombel, Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn’s disease, Cochrane Database Syst. Rev. 5(5) (2018) Article ID CD012540 (43 pages); https://doi.org/10.1002/14651858.CD012540.pub2
- C. Eccleston, E. Fisher, K. H. Thomas, L. Hearn, S. Derry, C. Stannard, R. Knaggs and R. A. Moore, Interventions for the reduction of prescribed opioid use in chronic non-cancer pain, Cochrane Data‑ base Syst. Rev. 11(11) (2017) CD010323; https://doi.org/10.1002/14651858.CD010323.pub3
- C. J. Edwards, B. Fautrel, H. Schulze-Koops, T. W. J. Huizinga and K. Kruger, Dosing down with biologic therapies: a systematic review and clinicians’ perspective, Rheumatology (Oxford), 56(11) (2017) 1847–1856; https://doi.org/10.1093/rheumatology/kew464
- I. Hopper, R. Samuel, C. Hayward, A. Tonkin and H. Krum, Can medications be safely withdrawn in patients with stable chronic heart failure? systematic review and meta-analysis, J. Card. Fail. 20(7) (2014) 522–532; https://doi.org/10.1016/j.cardfail.2014.04.013
- M. Lamarre, M. Marcotte, D. Laurin, D. Furrer, I. Vedel, A. Tourigny, A. Giguère, P. H. Carmichael, R. Martines, J. Morais and E. Kröger, Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes, Arch. Osteoporos. 16(1) (2021) Article ID 133 (23 pages); https://doi.org/10.1007/s11657-021-01000-w
- S. Mathieson, C. G. Maher, G. E. Ferreira, M. Hamilton, J. Jansen, A. J. McLachlan, M. Underwood and C. C. Lin, Deprescribing opioids in chronic non-cancer pain: systematic review of randomised trials, Drugs 80(15) (2020) 1563–1576; https://doi.org/10.1007/s40265-020-01368-y
- L. M Verhoef, B. J. van den Bemt, A. van der Maas, J. E. Vriezekolk, M. E. Hulscher, F. H. van den Hoogen, W. C. Jacobs, N. van Herwaarden and A. A. den Broeder, Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity, Cochrane Database Syst. Rev. 5(5) (2019) Article ID CD010455 (96 pages); https://doi.org/10.1002/14651858.CD010455.pub3
- R. White, L. Bruggink, C. Hayes, A. Boyes and C. Paul, Feasibility of patient-focused behavioral interventions to support adults experiencing chronic noncancer pain during opioid tapering: a systematic literature review, Transl. Behav. Med. 11(8) (2021) 1481–1494; https://doi.org/10.1093/tbm/ibab007
- A. Zorrilla-Vaca, G. E. Mena, P. T. Ramirez, B. H. Lee, A. Sideris and C. L. Wu, Effectiveness of peri-operative opioid educational initiatives: a systematic review and meta-analysis, Anesth. Analg. 134(5) (2022) 940–951; https://doi.org/10.1213/ANE.0000000000005634
- W. D. Lohr, J. W. Wanta, M. Baker, E. Grudnikoff, W. Morgan, D. Chhabra and T. Lee, Intentional discontinuation of psychostimulants used to treat ADHD in youth: a review and analysis, Front. Psychiatry 12(2021) ) Article ID 642798 (14 pages); https://doi.org/10.3389/fpsyt.2021.642798
- G. H. van de Loo-Neus, N. Rommelse and J. K. Buitelaar, To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?, Eur. Neuropsycho‑ pharmacol. 21(8) (2011) 584–599; https://doi.org/10.1016/j.euroneuro.2011.03.008
- F. Ayuga Loro, E. Gisbert Tijeras and F. Brigo, Rapid versus slow withdrawal of antiepileptic drugs, Cochrane Database Syst. Rev. 1(1) (2022) Article ID CD005003 (32 pages); https://doi.org/10.1002/14651858.CD005003.pub4
- E. G. Dixon, C. King, A. Lilley, I. P. Sinha and D. B. Hawcutt, Deprescribing montelukast in children with asthma: a systematic review, BMJ Open 12(1) (2022) Article ID e053112 (8 pages); https://doi.org/10.1136/bmjopen-2021-053112
- S. Iyer, V. Naganathan, A. J. McLachlan and D. G. Le Couteur, Medication withdrawal trials in people aged 65 years and older: a systematic review, Drugs Aging 25(12) (2008) 1021–1031; https://doi.org/10.2165/0002512-200825120-00004
- S. W. Narayan and P. S. Nishtala, Discontinuation of preventive medicines in older people with limited life expectancy: a systematic review, Drugs Aging 34(10) (2017) 767–776; https://doi.org/10.1007/s40266-017-0487-1
- S. Crisafulli, N. Luxi, R. Coppini, A. Capuano, C. Scavone, A. Zinzi, S. Vecchi, G. Onder, J. Sultana and G. Trifirò, Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials, BMC Fam. Pract. 22(1) (2021) 208; https://doi.org/10.1186/s12875-021-01557-y
- E. Reeve, V. Jordan, W. Thompson, M. Sawan, A. Todd, T. M. Gammie, I. Hopper, S. N. Hilmer and D. Gnjidic, Withdrawal of antihypertensive drugs in older people, Cochrane Database Syst. Rev. 6(6) (2020) Article ID CD012572 (59 pages); https://doi.org/10.1002/14651858.CD012572.pub2
- C. Hernández-Prats, E. López-Pintor and B. Lumbreras, Pharmacist-led intervention on the reduction of inappropriate medication use in patients with heart failure: a systematic review of randomized trials and non-randomized intervention studies, Res. Social. Adm. Pharm. 18(5) (2022) 2748–2756; https://doi.org/10.1016/j.sapharm.2021.06.023
- N. Arulkumaran, M. Khpal, K. Tam, A. Baheerathan, C. Corredor and M. Singer, Effect of anti biotic discontinuation strategies on mortality and infectious complications in critically ill septic patients: a meta-analysis and trial sequential analysis, Crit. Care Med. 48(5) (2020) 757–764; https://doi.org/10.1097/CCM.0000000000004267
- R. S. Bourne, J. K. Jennings, M. Panagioti, A. Hodkinson, A. Sutton and D. M. Ashcroft, Medication--related interventions to improve medication safety and patient outcomes on transition from adult intensive care settings: a systematic review and meta-analysis, BMJ Qual. Saf. 31(8) (2022) 609–622; https://doi.org/10.1136/bmjqs-2021-013760
- M. Cardona, P. Stehlik, P. Fawzy, O. Byambasuren, J. Anderson, J. Clark, S. Sun and I. Scott, Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic review, Expert Opin. Drug Saf. 20(1) (2021) 81–91; https://doi.org/10.1080/14740338.2021.1853704
- S. W. Lam, S. R. Bauer, R. Fowler and A. Duggal, Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies, Crit. Care Med. 46(5) (2018) 684–690; https://doi.org/10.1097/CCM.0000000000002953
- J. Lee, A. Negm, R. Peters, E. K. C. Wong and A. Holbrook, Deprescribing fall-risk increasing drugs (FRIDs) for the prevention of falls and fall-related complications: a systematic review and meta-analysis, BMJ Open 11(2) (2021) Article ID e035978 (10 pages); https://doi.org/10.1136/bmjopen-2019-035978
- J. W. Lee, M. Li, C. M. Boyd, A. R. Green and S. L. Szanton, Preoperative deprescribing for medical optimization of older adults undergoing surgery: a systematic review, J. Am. Med. Dir. Assoc. 23(4) (2022) 528–536.e2; https://doi.org/10.1016/j.jamda.2021.11.005
- D. Saeed, G. Carter and C. Parsons, Interventions to improve medicines optimisation in frail older patients in secondary and acute care settings: a systematic review of randomised controlled trials and non-randomised studies, Int. J. Clin. Pharm. 44(1) (2022) 15–26; https://doi.org/10.1007/s11096-021-01354-8
- P. Schuetz, Y. Wirz, R. Sager, M. Christ-Crain, D. Stolz, M. Tamm, L. Bouadma, C. E. Luyt, M. Wolff, J. Chastre, F. Tubach, K. B. Kristoffersen, O. Burkhardt, T. Welte, S. Schroeder, V. Nobre, L. Wei, H. C. Bucher, N. Bhatnagar, D. Annane, K. Reinhart, A. Branche, P. Damas, M. Nijsten, D. W. de Lange, R. O. Deliberato, S. S. Lima, V. Maravić-Stojković, A. Verduri, B. Cao, Y. Shehabi, A. Beishuizen, J. S. Jensen, C. Corti, J. A. Van Oers, A. R. Falsey, E. de Jong, C. F. Oliveira, B. Beghe, M. Briel and B. Mueller, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, The Co‑ chrane Database Syst. Rev. 10(10) (2017) Article ID CD007498 (104 pages); https://doi.org/10.1002/14651858.CD007498.pub3
- N. J. Soni, D. J. Samson, J. L. Galaydick, V. Vats, E. S. Huang, N. Aronson and D. L. Pitrak, Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis, J. Hosp. Med. 8(9) (2013) 530–540; https://doi.org/10.1002/jhm.2067
- J. Thillainadesan, D. Gnjidic, S. Green and S. N. Hilmer, Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials, Drugs Aging 35(4) (2018) 303–319; https://doi.org/10.1007/s40266-018-0536-4
- M. U. Ali, D. Sherifali, D. Fitzpatrick-Lewis, M. Kenny, A. Liu, L. Lamarche, D. Mangin and P. Raina, Polypharmacy and mobility outcomes, Mech. Aging Dev. 192 (2020) Article ID 111356 (11 pages); https://doi.org/10.1016/j.mad.2020.111356
- H. E. Bloomfield, N. Greer, A. M. Linsky, J. Bolduc, T. Naidl, O. Vardeny, R. MacDonald, L. McKenzie and T. J. Wilt, Deprescribing for community-dwelling older adults: a systematic review and meta-analysis, J. Gen. Intern. Med. 35(11) (2020) 3323–3332; https://doi.org/10.1007/s11606-020-06089-2
- I. Bužančić, I. Kummer, M. Držaić and M. Ortner Hadžiabdić, Community-based pharmacists’ role in deprescribing: a systematic review, Br. J. Clin. Pharmacol. 88(2) (2022) 452–463; https://doi.org/10.1111/bcp.14947
- C. M. Christopher, K. C. Bhuvan, A. Blebil, D. Alex, M. I. M. Ibrahim, N. Ismail and A. A. Alrasheedy, Clinical and humanistic outcomes of community pharmacy-based healthcare interventions regarding medication use in older adults: a systematic review and meta-analysis, Healthcare 9(11) (2021) Article ID 1577 (18 pages); https://doi.org/10.3390/healthcare9111577
- H. Dills, K. Shah, B. Messinger-Rapport, K. Bradford and Q. Syed, Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials, J. Am. Med. Dir. Assoc. 19(11) (2018) 923–935.e2; https://doi.org/10.1016/j.jamda.2018.06.021
- S. Romano, D. Figueira, I. Teixeira and J. Perelman, Deprescribing interventions among community-dwelling older adults: a systematic review of economic evaluations, Pharmacoeconomics 40(3) (2022) 269–295; https://doi.org/10.1007/s40273-021-01120-8
- S. L. Thio, J. Nam, M. L. van Driel, T. Dirven and J. W. Blom, Effects of discontinuation of chronic medication in primary care: a systematic review of deprescribing trials, Br. J. Gen. Pract. 68(675) (2018) e663–e672; https://doi.org/10.3399/bjgp18X699041
- J. Ulley, D. Harrop, A. Ali, S. Alton and S. Fowler Davis, Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review, BMC Geriatr. 19(1) (2019) Article ID 15 (13 pages); https://doi.org/10.1186/s12877-019-1031-4
- C. H. Kua, V. S. L. Mak and S. W. Huey Lee, Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis, J. Am. Med. Dir. Assoc. 20(3) (2019) 362–372.e11; https://doi.org/10.1016/j.jamda.2018.10.026
- M. Steinman and E. Reeve, UpToDate: Deprescribing, April 2021; https://www.uptodate.com/contents/deprescribing?search=deprescribing&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#disclaimerContent; last access date September 1, 2022.
- A. T. Page, R. M. Clifford, K. Potter, D. Schwartz and C. D. Etherton-Beer, The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis, Br. J. Clin. Pharmacol. 82(3) (2016) 583–623; https://doi.org/10.1111/bcp.12975
- R. Ostini, C. Jackson, D. Hegney and S. E. Tett, How is medication prescribing ceased? a systematic review, Med. Care 49(1) (2011) 24–36; https://doi.org/10.1097/MLR.0b013e3181ef9a7e
- S. Shrestha, A. Poudel, M. Cardona, K. J. Steadman and L. M. Nissen, Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis, Ther. Adv. Drug Saf. 12 (2021) Article ID 20420986211052343 (16 pages); https://doi.org/10.1177/20420986211052343
- A. H. Abdelhafiz and A. J. Sinclair, Deintensification of hypoglycaemic medications-use of a s ystematic review approach to highlight safety concerns in older people with type 2 diabetes, J. Diabetes Complications 32(4) (2018) 444–450; https://doi.org/10.1016/j.jdiacomp.2017.11.011
- J. A. Pruskowski, S. Springer, C. T. Thorpe, M. Klein-Fedyshin and S. M. Handler, Does deprescribing improve quality of life? A systematic review of the literature, Drugs Aging 36(12) (2019) 1097–1110; https://doi.org/10.1007/s40266-019-00717-1
- J. W. Blom, C. Muth, P. Glasziou, J. P. McCormack, R. Perera, R. K. E. Poortvliet, M. E. Numans, P. Thürmann, U. Thiem, S. L. Thio, M. Van Driel, M. Beyer, M. Van den Akker and J. A. Knottnerus, Describing deprescribing trials better: an elaboration of the CONSORT statement, J. Clin. Epidemiol. 127 (2020) 87–95; https://doi.org/10.1016/j.jclinepi.2020.07.011
- C. R. Hansen, D. O’Mahony, P. M. Kearney, L. J. Sahm, S. Cullinan, C. J. A. Huibers, S. Thevelin, A. W. S. Rutjes, W. Knol, S. Streit and S. Byrne, Identification of behaviour change techniques in depre-scribing interventions: a systematic review and meta-analysis, Br. J. Clin. Pharmacol. 84(12) (2018) 2716–2728; https://doi.org/10.1111/bcp.13742
- L. Monteiro, T. Maricoto, I. Solha, I. Ribeiro-Vaz, C. Martins and M. Monteiro-Soares, Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools: systematic review, J. Med. Internet Res. 21(11) (2019) e15385; https://doi.org/10.2196/15385
- S. Shrestha, A. Poudel, K. Steadman and L. Nissen, Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: a systematic review, Br. J. Clin. Pharmacol. 86(10) (2020) 1931–1945; https://doi.org/10.1111/bcp.14113
- S. Seidu, S. K. Kunutsor, P. Topsever, C. E. Hambling, F. X. Cos and K. Khunti, Deintensification in older patients with type 2 diabetes: a systematic review of approaches, rates and outcomes, Diabetes Obes. Metab. 21(7) (2019) 1668–1679; https://doi.org/10.1111/dom.13724
- V. Beslon, P. Moreau, A. Maruani, H. Maisonneuve, B. Giraudeau and J. P. Fournier, Effects of discontinuation of urate-lowering therapy: a systematic review, J. Gen. Intern. Med. 33(3) (2018) 358–366; https://doi.org/10.1007/s11606-017-4233-5
- Y. L. Chock, Y. L. Wee, S. L. Gan, K. W. Teoh, K. Y. Ng and S. W. H. Lee, How willing are patients or their caregivers to deprescribe: a systematic review and meta-analysis, J. Gen. Intern. Med. 36(12) (2021) 3830–3840; https://doi.org/10.1007/s11606-021-06965-5
- K. R. Weir, N. J. Ailabouni, C. R. Schneider, S. N. Hilmer and E. Reeve, Consumer attitudes towards deprescribing: a systematic review and meta-analysis, J. Gerontol. A Biol. Sci. Med. Sci. 77(5) (2022) 1020–1034; https://doi.org/10.1093/gerona/glab222
- M. P. Oktora, A. E. Edwina and P. Denig, Differences in older patients’ attitudes toward deprescribing at contextual and individual level, Front Public Health 10 (2022) Article ID 795043 (7 pages); https://doi.org/10.3389/fpubh.2022.795043
- M. Seewoodharry, K. Khunti, M. J. Davies, C. Gillies and S. Seidu, Attitudes of older adults and their carers towards de-prescribing: a systematic review, Diabetes Med. 39(7) (2022) Article ID e14801 (16 pages); https://doi.org/10.1111/dme.14801
- A. Burghle, C. Lundby, J. Ryg, J. Søndergaard, A. Pottegård, D. Nielsen and T. Graabæk, Attitudes towards deprescribing among older adults with limited life expectancy and their relatives: a systematic review, Drugs Aging 37(7) (2020) 503–520; https://doi.org/10.1007/s40266-020-00774-x
- A. J. Doherty, P. Boland, J. Reed, A. J. Clegg, A. M. Stephani, N. H. Williams, B. Shaw, L. Hedgecoe, R. Hill and L. Walker, Barriers and facilitators to deprescribing in primary care: a systematic review, BJGP Open 4(3) (2020) Article ID bjgpopen20X101096 (14 pages); https://doi.org/10.3399/bjgpopen20X101096
- H. Bloomfield, A. Linsky, J. Bolduc, N. Greer, T. Naidl, O. Vardeny, R. MacDonald, L. McKenzie and T. J. Wilt, Deprescribing for older veterans: a systematic review, Department of Veterans Affairs (US) (2019).
- K. Paque, R. Vander Stichele, M. Elseviers, K. Pardon, T. Dilles, L. Deliens and T. Christiaens, Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review, Palliat. Med. 33(1) (2019) 37–48; https://doi.org/10.1177/0269216318801124
- A. F. Rasmussen, S. S. Poulsen, L. I. K. Oldenburg and C. Vermehren, The barriers and facilitators of different stakeholders when deprescribing benzodiazepine receptor agonists in older patients-a systematic review, Metabolites 11(4) (2021) Article ID 254 (12 pages); https://doi.org/10.3390/meta-bo11040254
- E. Reeve, J. To, I. Hendrix, S. Shakib, M. S. Roberts and M. D. Wiese, Patient barriers to and enablers of deprescribing: a systematic review, Drugs Aging 30(10) (2013) 793–807; https://doi.org/10.1007/s40266-013-0106-8
- C. Stewart, K. Gallacher, A. Nakham, M. Cruickshank, R. Newlands, C. Bond, P. K. Myint, D. Bhattacharya and F. S. Mair, Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review, Int. J. Clin. Pharm. 43(6) (2021) 1451–1460; https://doi.org/10.1007/s11096-021-01293-4
- G. Clarke, S. Johnston, P. Corrie, I. Kuhn and S. Barclay, Withdrawal of anticancer therapy in advanced disease: a systematic literature review, BMC Cancer 15(2015) Article ID 892 (9 pages); https://doi.org/10.1186/s12885-015-1862-0
- E. Valdez-Martinez, J. Noyes and M. Bedolla, When to stop? Decision-making when children’s cancer treatment is no longer curative: a mixed-method systematic review, BMC Pediatr. 14 (2014) Article ID 124 (25 pages); https://doi.org/10.1186/1471-2431-14-124
- C. Lundby, T. Graabaek, J. Ryg, J. Søndergaard, A. Pottegård and D. S. Nielsen, Health care professionals’ attitudes towards deprescribing in older patients with limited life expectancy: a systematic review, Br. J. Clin. Pharmacol. 85(5) (2019) 868–892; https://doi.org/10.1111/bcp.13861
- K. Anderson, D. Stowasser, C. Freeman and I. Scott, Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis, BMJ Open 4(12) (2014) Article ID e006544 (18 pages); https://doi.org/10.1136/bmjopen-2014-006544
- A. E. Moth, P. Hølmkjær, A. Holm, M. P. Rozing and G. Overbeck, What makes deprescription of psychotropic drugs in nursing home residents with dementia so challenging? a qualitative systematic review of barriers and facilitators, Drugs Aging 38(8) (2021) 671–685; https://doi.org/10.1007/s40266-021-00875-1
- M. Michiels-Corsten, N. Gerlach, T. Schleef, U. Junius-Walker, N. Donner-Banzhoff and A. Viniol, Generic instruments for drug discontinuation in primary care: a systematic review, Br. J. Clin. Phar‑ macol. 86(7) (2020) 1251–1266; https://doi.org/10.1111/bcp.14287
- W. Thompson, C. Lundby, T. Graabaek, D. S. Nielsen, J. Ryg, J. Søndergaard and A. Pottegård, Tools for Deprescribing in frail older persons and those with limited life expectancy: a systematic review, J. Am. Geriatr. Soc. 67(1) (2019) 172–180; https://doi.org/10.1111/jgs.15616
- L. N. van Merendonk and M. Crul, Deprescribing in palliative patients with cancer: a concise review of tools and guidelines, Support Care Cancer 30(4) (2022) 2933–2943; https://doi.org/10.1007/s00520-021-06605-y
- B. N. Renn, A. A. Asghar-Ali, S. Thielke, A. Catic, S. R. Martini, B. G. Mitchell and M. E. Kunik, A systematic review of practice guidelines and recommendations for discontinuation of cholinesterase inhibitors in dementia, Am. J. Geriatr. Psychiatry 26(2) (2018) 134–147; https://doi.org/10.1016/j.jagp.2017.09.027
- M. A. van der Ploeg, C. Floriani, W. P. Achterberg, J. M. K. Bogaerts, J. Gussekloo, S. P. Mooijaart, S. Streit, R. K. E. Poortvliet and Y. M. Drewes, Recommendations for (discontinuation of) statin treatment in older adults: review of guidelines, J. Am. Geriatr. Soc. 68(2) (2020) 417–425; https://doi.org/10.1111/jgs.16219
- S. Darr-Foit, P. Elsner and J. Tittelbach, Deprescribing in dermatology: a systematic review of current dermatological guidelines, J. Dtsch. Dermatol. Ges. 17(3) (2019) 261–265; https://doi.org/10.1111/ddg.13759
- M. A. Fajardo, K. R. Weir, C. Bonner, D. Gnjidic and J. Jansen, Availability and readability of patient education materials for deprescribing: an environmental scan, Br. J. Clin. Pharmacol. 85(7) (2019) 1396–1406; https://doi.org/10.1111/bcp.13912
- A. J. Clough, S. N. Hilmer, S. L. Naismith, L. D. Kardell and D. Gnjidic, N-of-1 trials for assessing the effects of deprescribing medications on short-term clinical outcomes in older adults: a systematic review, J. Clin. Epidemiol. 93 (2018) 112–119; https://doi.org/10.1016/j.jclinepi.2017.09.015
- T. Morel, J. Nguyen-Soenen, W. Thompson and J. Fournier, Development and validation of search filters to identify articles on deprescribing in Medline and Embase, BMC Med. Res. Methodol. 22(79) (2022); https://doi.org/10.1186/s12874-022-01515-x
- T. Johansson, M. E. Abuzahra, S. Keller, E. Mann, B. Faller, C. Sommerauer, J. Höck, C. Löffler, A. Köchling, J. Schuler, M. Flamm and A. Sönnichsen, Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis, Br. J. Clin. Pharmacol. 82(2) (2016) 532–548; https://doi.org/10.1111/bcp.12959
- K. Ibrahim, N. J. Cox, J. M. Stevenson, S. Lim, S. D. S. Fraser and H. C. Roberts, A systematic review of the evidence for deprescribing interventions among older people living with frailty, BMC Geriatr. 21(1) (2021) 258; https://doi.org/10.1186/s12877-021-02208-8
- M. S. Salahudeen, A. Alfahmi, A. Farooq, M. Akhtar, S. Ajaz, S. Alotaibi, M. Faiz and S. Ali, Effectiveness of interventions to improve the anticholinergic prescribing practice in older adults: a systematic review, J. Clin. Med. 11(3) (2022) 714; https://doi.org/10.3390/jcm11030714102
- J. Lindsay, M. Dooley, J. Martin, M. Fay, A. Kearney and M. Barras, Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches, Support Care Cancer 22(4) (2014) 1113–1119; https://doi.org/10.1007/s00520-013-2098-7
- A. Nakham, P. K. Myint, C. M. Bond, R. Newlands, Y. K. Loke and M. Cruickshank, Interventions to reduce anticholinergic burden in adults aged 65 and older: a systematic review, J. Am. Med. Dir. Assoc. 21(2) (2020) 172–180.e5; https://doi.org/10.1016/j.jamda.2019.06.001